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ABSTRACT A robust discovery methodology is presented to identify novel biomaterials 
suitable for 3D printing. Currently the application of Additive Manufacturing is limited by the 
availability of functional inks, especially in the area of biomaterials-this method tackles this 
problem for the first time allowing hundreds of formulations to be readily assessed. Several 
functional properties, including the release of an antidepressive drug (paroxetine), cytotoxicity 
and printability are screened for 253 new ink formulations in a high-throughput format as well as 
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mechanical properties. The selected candidates with the desirable properties are successfully 
scaled up using 3D printing into a range of object architectures. A full drug release study, 
degradability and tensile modulus experiments are presented on a simple architecture to 
validating the suitability of this methodology to identify printable inks for 3D printing devices 
with bespoke properties. 
 
Introduction 
Additive Manufacturing, often termed 3D printing, is emerging as a technology with great 
potential for the manufacture of bespoke medical devices. Whilst there is some progress in 
identifying new materials for 3D printing,
1–4
 progress is slow and a limitation remains in the lack 
of functional materials that can currently be printed. 
5–10
 To address this challenge, we propose a 
high throughput screening approach to identify “inks” for 3D printing of functional materials. 
We exemplify this by targeting the identification of polymers printable using UV photo initiation 
for optimal bioresorbable drug delivery devices. The approach involves high throughput 
screening of a library of materials deposited as small polymer spots arranged as micro arrays, 
which are then used to identify which of the materials have the appropriate mechanical and cell 
compatibility properties. This surface-focused micro array screening approach is complemented 
by assessing larger samples in well-plates for bulk performance determination, which in this 
exemplification of the approach was quantification of drug release. From these high-throughput 
screening of different properties, 19 materials were shortlisted. A final selection was made based 
on an estimate of the printability, which led to the identification of materials that could be scaled 
up for 3D printing. Hit materials from the library were then used to fabricate drug-containing 
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objects suitable for subcutaneous implantation.
11
 Release profiles from these objects were 
quantified by standard drug dissolution testing procedures, illustrating the success of this 
approach in identifying new inks ready for use in the manufacture of bioresorbable medical 
devices by 3D printing.
12
 To the best of our knowledge, this is the first high throughput screening 
approach described for identifying inks for 3D printing or bioresobable drug delivery polymers. 
The method illustrated here offers opportunities in many other fields where new functional 3D 
printable materials are required. 
 
The main advantage of additive manufacturing with respect to traditional manufacturing 
techniques is the freedom of object design, providing an ideal opportunity for manufacturing 
personalized medicines
13
 and devices.
14,15
 Of the 3D printing technologies available, jetting of 
liquid inks to form solid materials
16
 enabled by piezoelectric inkjet methods allows for superior 
resolution
17,18
 when compared to other popular techniques such as extrusion (often used for 
bioprinting/cell printing).
19–21
 However, the range and functionality of materials available for 
inkjet printing are limited and a major barrier to the adoption of new materials is the printability 
requirements of a particular ink formulation, which needs to meet physical and rheological 
constraints in order to be ejectable from a nozzle.
22,23
 
 
Herein we explore a library of copolymers based on acrylated oligo or poly (β-amino ester)
 24–26
 
photo curable macromers (abbreviated to PBAE) and acrylic monomers, to identify suitable 
photocurable 3D printable ink formulations with a range of drug release properties. These 
bioresorbable materials based on acrylated β-amino esters (Figure 1a) are oligomeric (macromer) 
products from a Michael addition reaction and have enormous potential in applications where the 
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polymer is required to hydrolytically degrade in service, such as during or after drug delivery 
from an implant. To illustrate this, we have chosen paroxetine hydrochloride (Figure 1c), an 
antidepressant drug in a group of medicines called selective serotonin reuptake inhibitors. To 
overcome side effects related to treatments with paroxetine, such as cardiac arrhythmia or 
insomnia, extended release from a subcutaneous implant is a desirable strategy to reduce these 
serious side effects possible from oral systemic delivery over long periods of time.
27,28
 For our 
illustration of a high throughput screening study this drug has the advantage that it is auto 
fluorescent allowing us to use fluorescence spectrophotometry to quantify the drug released, but 
the 384 well plate format allows for the analysis of any compound using auto sampling methods 
and quantification by high performance liquid chromatography mass spectrometry. By 
examining drug release from well plated for up to 2 months in vitro, in addition to high 
throughput analysis of cytotoxicity and modulus, we selected candidate materials for scale-up to 
3D printing which were further refined by consideration of the printability of the inks. Objects 
suitable for subcutaneous implantation were successfully printed into a variety of forms with the 
selected ink and subjected to macroscopic tensile mechanical testing, drug release and polymer 
degradation studies.  
 
Results and Discussion 
 
Polymer library synthesis and micro array fabrication 
PBAEs are easily synthesized in bulk by a Michael addition reaction of primary amines (or a 
bis(secondary) amine) with diacrylates following the approach of Anderson et al.
24
 (Figure 1ab). 
The diacrylates were used in excess in order to preserve acrylate functionalities at both ends. A 
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total of 6 diacrylates (A-F, Figure 1a) and 6 amines (1-6, Figure 1a) were combined at 1.2 :1 
diacrylate/amine molar ratio to give rise to 36 macromers in principle, identified as diacrylate-
amine (letter-number) code according to Figure 1a (Table S1, Supporting Information). To 
further explore the effect of composition, the diacrylate/amine ratio was also modified to 1.2:1, 
1.5:1 and 2:1 in one case (identified as C3, C3-15 and C3-2 respectively). Diacrylate C was 
further combined with another three amines 7-9 to form a total of 42 macromers. 
 
Page 5 of 29
ACS Paragon Plus Environment
ACS Applied Materials & Interfaces
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 6
Figure 1. (a) Chemical structures of the diacrylates (A-F) and amines (1-9) used to synthesise 
the PBAE macromers and methacrylamide G. (b) General structure of PBAE macromers. (c) 
Chemical structure of paroxetine hydrochloride. 
While piezoelectric 3D printing is highly sensitive to ink viscosity, this is not the case with 
pin-printing where grooved reservoirs in metal pins are filled by capillary forces on immersion 
into liquid inks. This technique allows for microarray preparation of a very wide range of inks 
which we printed prior to high throughput characterization of the UV cured spots in the 
accessible form of a polymer micro array.
29–34
 Pure PBAE are in general too viscous for 
piezoelectric ink jet printing. The microarray strategy allows for the rapid screening of a large 
amount of materials by combining PBAE and diacrylate monomers (A-F). 
Combinatorial mixtures of 42 PBAEs and 6 diacrylates and one acrylamide (mixed with both 
PBAE and diacrylates, Figure 1a) gave rise to 253 materials. To prepare the library as both micro 
arrays on glass slides and in well-plates, PBAE and monomer G were mixed with diacrylates A-
F (1:1 w/w ratio). The solvent (DMF, bp=153°C) and any eventual unreacted volatile monomer 
(i.e. E, bp=162°C) were removed after polymerization in a vacuum oven as indicated by surface 
chemical characterization techniques (ToF-SIMS, Supporting Information). The co-polymers are 
identified as diacrylate (A-G) with PBAE (from A1 to F6), resulting in copolymers denoted in 
this form, AA1 to GF6. 
 
High throughput micro array assessment 
The polymer microarrays were used to carry out high throughput cytotoxicity assessment, 
mechanical property measurements using atomic force microscopy (AFM) and surface chemical 
characterization (Figure 2) by ToF-SIMS (Supporting Information, Figures S15).
30,29
 High 
throughput measurement of the elastic modulus was achieved using automated AFM analysis of 
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the array (Figure 2b) by PeakForce quantitative nanomechanics (QNM) imaging mode, revealing 
a wide range of elastic moduli throughout had been achieved on the polymer library.  
 
Figure 2. (a) Schematic workflow depicting the high-throughput methodologies applied and 
material selection at the different steps. (b) Elastic moduli represented as interval values in MPa 
ranked from lower (left) to upper values. For clarity, the values represented in purple (up to 100 
MPa) are plotted on an expanded scale. 
In the novel high throughput polymer micro array cytotoxicity assay, dye penetration and cell 
number quantification indicated a slight reduction in mesenchymal stem cell viability after 48 
hours of culture for all polymer spots (Supporting Information, Figure 3b and Figure S8). This is 
consistent with a previous report noting such an effect ascribed to degradation products of 
PBAE,
35
 although the cell survival and viability was still high compared to the cytotoxic effect 
induced by a cyanoacrylate as a comparator (Figure 3b and Figure S8). For the PBAE library 
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under investigation, no component showed a specifically detrimental effect so all material 
chemistries went forward for further consideration. 
Polymer mechanical properties are relevant to biomaterial application, and consequently we 
have developed a high throughput method to determine stiffness modulus from the micro array 
format and provide choice of material further downstream.
36–40
 AFM has previously been used in 
a high-throughput to morphologically characterize polymer micro arrays but not previously to 
determine modulus.
34
 PeakForce QNM, which allows simultaneous imaging and mechanical 
property measurement was used to automatically analyze all the spots on the microarray. The 
information acquired provides the Derjaguin–Muller–Toporov (DMT) modulus
41,42 
amongst 
other sample properties. Cantilevers suitable for the measurement of moduli between 5 and 2000 
MPa were used to obtain quantitative measurements across most of the polymers (see Supporting 
Information for details).
42–45
 Due to the uncertainty of the geometrical models used to represent 
the probe tips, it is most appropriate to present these data as ranges of elastic moduli instead of 
discrete values (Figure 2b). Moduli were measured ranging from 1 MPa to 5 GPa. To put these 
moduli in context, medical polyurethanes fall in the range of 5-7 MPa, PDMS ranges from 48 
kPa up to 2 MPa,
46
 mixtures of PDMS and polyurethane are used measuring a few (15-35) 
MPa,
47
 subcutaneous tissue around 4 kPa,
48
 dermis 2.8-4 MPa
49
 and human bone is found in the 
range of 3-20 GPa.
50
 Flexible and intermediate modulus materials with a stiffness in the MPa 
range are thought to be most suitable for subcutaneous implantation to achieve a balance of 
mechanical stability and flexibility.
47
 The range of material moduli achieved in this library of 
bioresorbable materials offers a route to tuning the material to the desired function. 
 
Library fabrication in well plates for drug release quantification 
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Ready determination of drug release requires separate compartments into which the eluted 
drug can be collected and quantified in solution. Consequently, the library was photocured in a 
384 well-plate format, where each well contained a solution of the drug and the photo initiator 
[2% in DMF, 2,2-dimethoxy-2-phenylacetophenone (DMPA)] added to the diacrylate-PBAE 
mixtures in 70% DMF (w/v), so as to achieve 100 ng of drug per well. The drug loading was 
chosen such that the release concentration was within limits required in the body.
51,52
 After UV 
curing and vacuum drying, the samples were incubated in 100 µL phosphate buffered saline 
(PBS, pH 7.4). At selection times, 75 µL of the dissolution media was transferred to black 
polystyrene plates for fluorescence measurements (λex=270, λem=335) by using an automatic 
pipetting robot (Biotek). The experiments were performed in triplicate and included a control 
plate containing the (co)polymers without drug as a background. The release profiles for the 
materials are presented in Figure 3a for times up to 2 months. These reveal a wide range of 
release rates from the polymers: for ease of visual interpretation, only the 20 h and 2 month time 
points of release are shown from the 1 h time point measurements made up to 2 months (Figures 
S1-S6).   
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Figure 3. (a) Cumulative paroxetine release for the materials ordered from lower (left) to higher 
(right) cumulative release at 20h (red). Release after 2 months (64 days) is depicted in blue. (b) 
Normalized cell viability quantified from the Neutral Red stain for the PBAE materials. Green 
bars show negative controls (left to right: bare glass and pHEMA-coated glass), the red bar the 
positive control (cyanoacrylate adhesive). (c) Release profile after one month (31 days, orange 
dots) and AFM determined elastic modulus intervals (blue bars) for 19 materials. (d) Cumulative 
kinetic release profile for 2 of the hit materials, over 31 days. All error bars depict standard 
deviation from the mean. 
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A number of materials, desirable for extended release in that they follow a near zero-order
53,54
 
release profile were identified (Figure 3). Nineteen polymers were selected as of interest based 
on linear release profile. All of them also showed an initial burst release (Figure 3 and Figure S7) 
commonly observed in commercial formulations of drugs from polymer drug delivery 
matrices
53,11
 including polyurethane (PU),
55
 polydimethylsiloxane (PDMS)
56,57
 or poly(ethylene 
vinyl acetate),
58
 PLGA and methacrylate based materials.
53
 This is beneficial in some situations, 
in the case of paroxetine, an initial amount in blood might be desirable to reach a therapeutic 
level rapidly. 
 
Printability screening 
In order to test printability in a piezo electric system, a number of aspects of the ink 
formulations needed to be considered. Firstly, the 19 candidate materials showing near zero 
order release were reduced to 9 combinations based on the solubility of the PBAE in the 
diacrylate monomer without any additional solvent-for maximum simplicity, resulting in the use 
of only PBAE materials based on C and A. The resulting 9 combinations were then screened 
using the criteria of ejection from an automated piezo electric microarray printer (SciFlexarrayer 
S5, Scenion). This has similarities with inkjet 3D printers, but with the advantage of being able 
to simultaneously screen multiple inks utilising just 50 µl of each from a well plate in a fully 
automated manner. Although the high viscosity of our formulations does not allow for a high-
throughput printability screening by using system, it may be applied to low viscosity 
formulations in high-throughput format. Solvent dilution was used as a surrogate for increased 
temperature to reduce viscosity in the 3D printer. The inks were prepared at 6.25%, 12.5%, 25% 
and 50% in DMF (w/v) and 50 µl of each solution was transferred into 384 well plate (See 
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Supporting Information for details). Although all the inks could be aspirated and ejected under 
almost all levels of dilution, the drug was readily soluble in only the most hydrophilic monomers 
(D-F). From the 4 inks that dissolve the drug, only FC3-2 and EC3-15 could be ejected as drops 
at the minimum dilution and thus at the lowest temperature (Table 1 and Figure S9). 
Interestingly, these formulations involve both the C3 PBAE (tripropylene glycol combined with 
triethylamine at different ratios) copolymerized with polyethylene glycol (MW=500) and 
diethylene glycol (F and E, Figure 1) respectively. Several PBAE prepared from tripropylene 
glycol appear to be miscible with several diacrylates giving formulations suitable to be printed. 
These were therefore assessed to be the formulations most likely ready to be printed by using the 
original screened formulation without further adjustments for viscosity (i.e. increasing 
diacrylate/PBAE ratio). The elastic modulus of these was also within the MPa range (Figure 3c), 
suitable to prepare drug delivery subcutaneous implants.
47
 This method was able to predict the 
two formulations ultimately found to be printable, indicating its suitability for rapid assessment 
of candidate materials for 3D printing. 
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Table 1. Printability screening results (A= aspirated and E= ejected) for the 9 inks prepared at 
25% and 50% in DMF (w/v). 
Ink (%)
[a]
 25% 50% 
Ink A E A E 
BA3 x x x x 
BC3 √ √ x x 
C3 √ √ x x 
CC4 √ √ x x 
CC5 √ √ x x 
EA2 √ x x x 
FC3-2 √ √ √ √ 
EC3-12 √ √ x x 
EC3-15 √ √ √ x 
[a]
 Percentage of the ink in the formulation with DMF  
 
Scale up of hit polymers using UV photo initiated inkjet printing 
As a consequence of the screening protocols, the two formulations identified (FC3-2 and EC3-
15) were shown to produce materials with a near-zero order release profile (Figure 3cd) and were 
suitable for 3D printing (Table 1). Additionally, they proved to be non-toxic to cells (Figure 2b 
and S8) and the modulus was within the range of commonly utilized biomedical elastomers 
(Figure 3c) 
47,11
. Both the measured viscosity and the surface tension of the ink formulations 
selected for scale up were in the appropriate range for printability, both with and without drug at 
a temperature of 60°C, i.e. between 10-13 cP, with the range of 9-15 cP recognized as optimal
22
 
(Table 2 and Figure S12). The two candidate materials were found to be dispensable on a 
commercial inkjet printer (Dimatix DMP 2800) by using standard waveforms (suitable to print 
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commercial UV curable inks) where single spherical drops without satellites were achievable just 
through the adjustment of the cartridge working temperature (between 25 and 70°C in all cases). 
In order to test the predictability of our printability screening, an ink predicted to not be printable 
from the high throughput test (BA3 in Table 1) was checked for dispensing, and was found not to 
be printable on the Dimatix DMP 2800 by using standard waveforms at the highest temperature 
available (70 °C), giving us confidence that our method is able to discriminate between inks that 
can and can’t be used for 3D printing. Scale up was demonstrated by successfully printing 
different objects from both inks (Figure 4c-h) on polyethylene terephthalate (PET) foil using 6 of 
the available 16 nozzles simultaneously, with curing initiated through concurrent illumination of 
UV during each pass of the print head. Simple objects of various geometries were produced 
including squares, rectangles, grids and a honeycomb using the number of layers to control 
thickness between 0.1 to 0.6mm; control of architecture is a powerful route to control release.
59
  
Table 2. Viscosity at printing temperatures and surface tension measured both with and without 
drug incorporated paroxetine in the ink formulation. 
 FC3-2 EC3-15 
Viscosity [MPa.s]
[a]
 13.18±0.36 10.61±0.10 
Surface tension 
[mN.m
-1
]
[b]
 
32.81±0.21 31.96±0.11 
Surface tension 
[mN.m
-1
]
[c]
 
33.11±0.23 32.75±0.38 
[a]
Data at printing temperature (60 C); 
[b]
 RT; 
[c]
 RT containing 1 mg/mL paroxetine 
hydrochloride. 
 
A full object characterization involving drug release, polymer degradability and mechanical 
characterization for the FC3-2 material was achieved by printing cm sized squares (25 layers, 
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113 µm thick, 1x1 cm) and rectangles (30 layers, 137 µm thick, 1x2.5 cm) (Figures 4b, S10 and 
4a respectively). The tensile test moduli measurements revealed an average elastic modulus of 
1.55 ± 0.08 MPa (Figure 4a, see Supporting Information for details), within the range of 
biomedical used elastomers. This result is one order of magnitude lower than the surface DMT 
modulus estimated by Peak Force QNM AFM. Such difference between nanoscale surface and 
bulk measurements are not uncommon, reflecting both the very different methods used and that 
the surface can have quite different physical properties to the bulk. This does not detract from the 
utility of the AFM based approach to achieve high throughput screening of a large number of 
materials using their relative moduli measurements. 
 
Drug release and degradability experiments were performed with 5 replicates of 1 cm
2
 printed 
squares of FC3-2 (25 layers) by immersing the printed materials in PBS to such a volume that 
upon elution of all drug the concentration reached would be 10 µg/mL, and incubated at 37°C 
(Figure 4b). The thin film geometry was selected as a simple starting point from which shape can 
be adjusted in the future for fine-tuning of drug release according to personalized requirements. 
The linear behavior and burst effect is maintained when scaling-up, which illustrates the success 
and suitability of the screening methodology proposed. 
 The current demonstration system is suitable for commencing in vitro studies to assess the 
actual effect of geometry in vivo and in preclinical animal models. 
For a future local implant, those devices show the potential to maintain a therapeutically local 
drug concentration over at least three months. Hydrolytic degradation experiments with 
analogous samples without incorporating the drug were performed (Figure S14). The mass loss 
recorded on an initially weekly, then bi-weekly basis showed a degradation of the polymer 
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slower than the drug release. This is consistent with polymer degradation not being the only 
mechanism of release, but rather diffusion of the active from the polymer plays a major role as 
observed for commercially biodegradable polymers.
60
  
 
 
Figure 4. (a) Results of tensile experiments (4 replicates) representing stress (MPa) vs. 
percentage of strain. The slope of the linear part is the elastic Young modulus (E). (b) 
Comparison of the cumulative paroxetine release profile of FC3-2 printed 1 cm
2
 squares (25 
layers, 5 replicates, blue) and HT screening in well plates (orange, 3 replicates. Note that the 
release should be completed at day 42, prior to the last measurement). (c- h) Exemplary pictures 
(c, e, f, h) and micrographs (d,g) of printed structures: (c) FC3-2 grid, 99 and (d) 50 layers, (e) 
FC3-2 1x1 cm 25-layer squares, (f) 1x1 cm 5-layer honeycomb (g) EC3-15 grid, 20 layers  and 
(h) EC3-15 25-layer 1x1 cm square. 
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Conclusions 
In summary, we have developed the first high-throughput screening methodology to identify 
3D printable inks, exemplified here using UV curable bioresorbable co-polymers with drug 
release properties relevant to releasing implants; near zero order release profile compatible with 
drug concentration close to therapeutic levels. The 3D printability of hit materials was assessed 
to identify inks for scale up to objects that exhibited extended and linear drug release profiles 
achieving therapeutic concentrations and appropriate elastic modulus for biomedical devices. 
The UV initiated inkjet printing approach was used to achieve different object geometries 
illustrating the flexibility of form that can be achieved. High throughput cytotoxicity experiments 
were developed based on polymer micro arrays on which high throughput elastic modulus 
measurements were also undertaken for the first time. This information was complemented by 
applying ToF SIMS as high throughput surface chemical characterisation method. The 
methodology described herein is proposed as a robust tool to identify novel printable functional 
materials which we see being of great utility to the emergence of 3D printing in biomedicine and 
may readily be combined with other high-throughput material screening methods in the 
biomaterials field such as cell attachment, bacterial resistance and immune modulation. 
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